Burden, A. David
Article History
Received: 20 February 2024
Accepted: 1 March 2024
First Online: 5 April 2024
Declarations
:
: David Burden reports receiving consulting fees from AbbVie, Almirall, BMS, Boehringer Ingelheim, Celgene, Bristol Myers Squibb, Eli Lilly, Janssen, LEO Pharma, Novartis and Union Chimique Belge (UCB) and payment or honoraria for lectures and presentations from Almirall, Boehringer Ingelheim, Eli Lilly and Janssen.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals.